Canadian Psychiatric Association

Editorial Credits/ Crédits éditorials

Subscription Rates /Prix d'abonnements

Advertising Rates / Tarifs publicitaires (PDF)

Guest Editorial
Eating Disorders
Paul E. Garfinkel
PDF

In Review
Pharmacologic Treatment of Eating Disorders
April J Zhu, B Timothy Walsh
PDF

Psychological Treatments for Anorexia Nervosa: A Review of Published Studies and Promising New Directions
Allan S Kaplan

PDF

Original Research
Acute Psychiatric Inpatient Care for People With a Dual Diagnosis: Patient Profiles and Lengths of Stay

Philip Burge, Hélène Ouellette-Kuntz, Haider Saeed, Bruce McCreary, Dana Paquette, Franklin Sim

PDF

Canadian Geriatric Psychiatrists: Why Do They Do It? A Delphi Study
Susan Lieff, Diana Clarke

PDF

Relation of Blood Counts During Clozapine Treatment to Serum Concentrations of Clozapine and Nor-Clozapine
L Kola Oyewumi, Zack Z Cernovsky, David J Freeman, David L Streiner

PDF

Research Methods in Psychiatry
Breaking Up is Hard to Do: The Heartbreak of Dichotomizing Continuous Data
David L Streiner

PDF

Brief Communciation
Treatment Resistance in Anorexia Nervosa and the Pervasiveness of Ethics in Clinical Decision making
Chris MacDonald

PDF

Topiramate Use in Obese Patients With Binge Eating Disorder: An Open Study
Jose C Appolinario, Leonardo F Fontenelle, Marcelo Papelbaum, Joao R Bueno, Walmir Coutinho

PDF


Book Reviews

The Depressed Child and Adolescent. 2nd ed.

Clinical Assessment of Dangerousness: Empirical Contributions

The Feeling of What Happens: Body and Emotion in the Making of Consciousness

The Evolution of Psychoanalysis: Contemporary Theory and Practice

Psychiatrie gériatrique: esquisse d'une histoire médicale par l'élaboration de son langage

Démystifier les maladies mentales: les troubles de l'enfance et de l'adolescence


Books Received


Letters to the Editor

RE: Who Develops Severe or Fatal Adverse Drug Reactions to Selective Serotonin Reuptake Inhibitors?

RE: Canadian and American Psychiatrists' Attitudes Toward Dissociative Disorder Diagnoses

Acute Onset of Schizophrenia Following Autocastration

The World Trade Center Disaster

Selenium, Thyroid Hormones, Mood, and Behaviour

Letters to the Editor

Selenium, Thyroid Hormones, Mood, and Behaviour

Dear Editor:

It has been well known for many years that both hypo- and hyperthyroidism may cause various psychiatric symptoms (1). Both hypo- and hyperthyroidism may be associated with changes in mood, behaviour, and cognitive function. There is substantial evidence that small changes in thyroid function may be biologically meaningful and affect mood and behaviour (2).

Selenium is required for appropriate thyroid hormone synthesis, activation, and metabolism (3,4). Among all organs, the human thyroid gland has the highest selenium content per gram of tissue. Low selenium status may compromise thyroid hormone metabolism. Low selenium status can be a result of low selenium intake (4). Selenium concentration in blood and tissue can also be affected in patients with chronic renal failure treated by hemodialysis or by chronic peritoneal dialysis (5).

Considerable evidence suggests that selenium deprivation leads to depressed mood, and high dietary or supplementary selenium seems to improve mood (4,6). Several research groups have found that low selenium status is associated with a significantly increased incidence of depression, anxiety, confusion, and hostility (4,6). Low plasma selenium concentrations in the elderly have been significantly associated with senility and cognitive decline (7). Therefore, it is reasonable to suggest that the effect of selenium status on mood, behaviour, and cognition may be partly mediated by changes in thyroid function induced by selenium deficiency or selenium supplementation.

Iodine prophylaxis was initiated during the 1920s. Future studies may answer the question whether, in addition to iodine prophylaxis, we also need selenium supplementation to optimize the function of the thyroid axis.


References

1. Haggerty JJ, Garbutt JC, Evans DL, Golden RN, Pedersen C, Simon JS, and others. Subclinical hypothyroidism: A review of neuropsychiatric aspects. Int J Psychiatry Med 1990;20:193–208.

2. Sher L, Rosenthal NE, Wehr TA. Free thyroxine and thyroid-stimulating hormone levels in patients with seasonal affective disorder and matched controls. J Affect Disord 1999;56:195–9.

3. Koehrle J. The trace element selenium and the thyroid gland. Biochimie 1999;81:527–33.

4. Rayman MP. The importance of selenium to human health. Lancet 2000;356:233–41.

5. Zima T, Mestek O, Nemecek K, Bartova V, Fialova J, Tesar V, Suchanek M. Trace elements in hemodialysis and continuous ambulatory peritoneal dialysis patients. Blood Purif 1998;16:253–60.

6. Benton D, Cook R. Selenium supplementation improves mood in a double-blind crossover trial. Biol Psychiatry 1991;29:1092–8.

7. Berr C, Balansard B, Arnaud J, Roussel AM, Alperovitch A. Cognitive decline is associated with systemic oxidative stress—the EVA study. J Am Geriat Soc 2000;48:1285–91.

Leo Sher, MD
Riverdale, New York